(Q45105371)

9 December 2017

title

Factors contributing to ribavirin-induced anemia (English)

1 reference

9 December 2017

1 reference

12

Seizaburo Kashiwagi

1 reference

9 December 2017

Hideyuki Nomura

1

1 reference

9 December 2017

Hironori Tanimoto

2

1 reference

9 December 2017

Eiji Kajiwara

3

1 reference

9 December 2017

Junya Shimono

4

1 reference

9 December 2017

Toshihiro Maruyama

5

1 reference

9 December 2017

Nobuyuki Yamashita

6

1 reference

9 December 2017

Masanori Nagano

7

1 reference

9 December 2017

Masashi Higashi

8

1 reference

9 December 2017

Tamotsu Mukai

9

1 reference

9 December 2017

Yutaka Matsui

10

1 reference

9 December 2017

Jun Hayashi

11

1 reference

9 December 2017

Hiromi Ishibashi

13

1 reference

9 December 2017

publication date

1 November 2004

1 reference

Journal of Gastroenterology and Hepatology

9 December 2017

published in

1 reference

9 December 2017

volume

19

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

1312-1317

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Factors influencing ribavirin-induced hemolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

Viral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03459.X

10.1111/J.1440-1746.2004.03459.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference